Heart Disease Clinical Trials in Los Angeles

Showing 141-160 of 333 trials

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

NCT00326690

The purpose of the present prospective, randomized study is to investigate the clinical effectiveness of standardized left ventricular reconstruction surgery (LVR). In order to standardize the procedure, the operation will be performed with the Blue Egg, manufactured by BioVentrix, a subsidiary of CHF Technologies, Inc.

Congestive Heart FailureIschemic CardiomyopathyCoronary Artery Disease+1 more

BioVentrixStarted Nov 2005

Los Angeles, California, United States • St. Petersburg, Florida, United States • Baltimore, Maryland, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure

NCT00303498

The aim of this study was to determine whether long-term (≥ 6 months at the target dose) blockade of ETA receptors using sitaxsentan showed functional benefit in subjects with chronic Heart Failure and an Left Ventricular Ejection Fraction ≥50%.

Diastolic Heart Failure

Pfizer200 participantsStarted Mar 2006

Birmingham, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +49 more locations

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure

Heart Disease Trials in Other Cities

Vascular Inflammation in Psoriasis - Apremilast

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Cognitive Intervention to Improve Working Memory

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

Safety and Efficacy Study of AI LVEF

SHIELD II Clinical Investigation

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Other Conditions in Los Angeles